Endobariatrics in the era of glucagon-like peptide-1 receptor agonists: evolving roles, evidence, and integration

By afschroeder • October 1, 2025

Vahedi F, Yalamanchi M, Issa D. Endobariatrics in the era of glucagon-like peptide-1 receptor agonists: evolving roles, evidence, and integration. Curr Opin Gastroenterol. 2025 Nov 1;41(6):380-388. doi: 10.1097/MOG.0000000000001134. Epub 2025 Oct 2. PMID: 41025685.

Tags: Digestive Diseases, endobariatric therapy, endoscopic sleeve gastroplasty, Fellow, General Internal Medicine, glucagon-like peptide-1 receptor agonists, Obesity, obesity management, Olive View DoM, Publications, Resident

Related Posts

Corrigendum to “Subchronic inhalation exposure to ultrafine particulate matter alters the intestinal microbiome in various mouse models” [Environ. Res. 248 (2024) 118242]

Chang C, Gupta R, Sedighian F, Louie A, Gonzalez DM, Le C, Cho JM, Park SK, Castellanos J, Ting TW, Dong TS, Arias-Jayo N, Lagishetty[...]

Effectiveness of transoral endoscopic fundoplication with or without hiatal hernia repair in patients with gerd and chronic cough

Swei E, Almario JA, Dunbar K, Yadlapati R, Parker B, Brewer-Gutierrez O, Janu P, Murray M, Sohagia A, Diehl DL, Khara H, Abu Dayyeh B,[...]

Identification of a PRDM1-regulated T cell network to regulate atherosclerotic plaque inflammation

Jin H, Maas SL, Zou Y, Lu C, Yu B, Huchzermeier R, Nadeau S, Dos Santos J, Gijbels M, Mees BME, Smirnov E, Matic L,[...]